Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05919771 · ClinicalTrials.gov registry record
Effects of Rock Climbing on Parkinson's Disease
A clinical trial, sponsored by Marymount University.
- Completed
- Registry status
- 32
- Enrollment target
NCT05919771: Completed study, sponsored by Marymount University.
NCT05919771 is a clinical trial that has completed, run by Marymount University. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05919771 has completed, sponsored by Marymount University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This research study is being conducted to understand the outcomes of participation in the Up ENDing Parkinson's rock climbing program (24 sessions, or twice per week for about 12 weeks) on walking \& mobility, hand strength \& dexterity, and psychological well-being in individuals with Parkinson's Disease (PD). The rock climbing sessions are administered and supervised by Up ENDing Parkinson's, and are tailored to the skill level of the participant. Participants will answer questionnaires and complete physical performance tests twice, first prior to beginning the sessions and then again after the 24 sessions have been completed.
Primary Outcome
Test of specific tasks to be accomplished to walk forward on a level surface safely and efficiently as evidence by the Community Balance and Mobility Scale (CBMS). CBMS is scored from 0-96 with higher scores denoting better performance.
Interventions
- OTHER rock climbing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2024-08-12 |
What the finished NCT05919771 record still lists
NCT05919771 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which rock climbing is the first listed.
NCT05919771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05919771 about?
NCT05919771 is a clinical study titled "Effects of Rock Climbing on Parkinson's Disease". This research study is being conducted to understand the outcomes of participation in the Up ENDing Parkinson's rock climbing program (24 sessions, or twice per week for about 12 weeks) on walking \& mobility, hand strength \& dexterity, and psychological well-being in individuals with Parkinson's D...
What is the current status of trial NCT05919771?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2023-07-12. Estimated completion is 2024-08-12.
What interventions are being tested in trial NCT05919771?
The interventions under investigation include: rock climbing (OTHER).
Who is sponsoring clinical trial NCT05919771?
This trial is sponsored by Marymount University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI